We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEWR
1726
DELISTED
New Relic, Inc.
NEWR
– –
-21,785
Closed -$2.15M
ICPT
1727
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-48,279
Closed -$5.4M
TRHC
1728
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
– –
-17,575
Closed -$992K
LTRPA
1729
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
– –
-1,984
Closed -$28K
RAD
1730
DELISTED
Rite Aid Corporation
RAD
– –
-123
Closed -$2K
CGRN
1731
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
– –
-2
Closed –
WWE
1732
DELISTED
World Wrestling Entertainment
WWE
– –
-22,425
Closed -$1.95M
RTL
1733
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
– –
-12,713
Closed -$137K
QUOT
1734
DELISTED
Quotient Technology Inc
QUOT
– –
-50,201
Closed -$496K
NEX
1735
DELISTED
NexTier Oilfield Solutions Inc.
NEX
– –
-1,500
Closed -$16K
FOCS
1736
DELISTED
Focus Financial Partners Inc. Class A
FOCS
– –
-6,469
Closed -$231K
UNVR
1737
DELISTED
Univar Solutions Inc.
UNVR
– –
-2,200
Closed -$49K
AJRD
1738
DELISTED
Aerojet Rocketdyne Holdings
AJRD
– –
-9,082
Closed -$323K
ATTO
1739
DELISTED
Atento S.A.
ATTO
– –
-1,668
Closed -$30K
ARDS
1740
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
– –
-19
Closed –
GLOP
1741
DELISTED
GASLOG PARTNERS LP
GLOP
– –
-3,351
Closed -$76K
EVLO
1742
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
– –
-109
Closed -$18K
HVBC
1743
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
– –
-2
Closed –
MNTV
1744
DELISTED
Momentive Global Inc. Common Stock
MNTV
– –
-35,946
Closed -$655K
AQUA
1745
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
– –
-11,650
Closed -$147K
BSMX
1746
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
– –
-385,072
Closed -$2.61M
SJR
1747
DELISTED
Shaw Communications Inc.
SJR
– –
-77,034
Closed -$1.6M
AIMC
1748
DELISTED
Altra Industrial Motion Corp
AIMC
– –
-77,097
Closed -$2.4M
SIOX
1749
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-1,466
Closed -$16K
OBSV
1750
DELISTED
ObsEva SA Ordinary Shares
OBSV
– –
-1,544
Closed -$20K
68 69
70
71 72

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.